FIELD: chemistry.
SUBSTANCE: invention relates to {2-(S)-hydroxy-3-[6-oxo-1,6-dihydropyridin-3-ylmethyl amino]propyl} (cyclohexylmethyl)phosphinic acid, with antagonistic effect on GABAB, which can be used as a pharmaceutical preparation.
EFFECT: obtaining new biologically active substance.
3 cl, 10 ex
Title | Year | Author | Number |
---|---|---|---|
OXADIAZOLE DERIVATIVES POSSESSING ANTI-TUMOR EFFECT, MEDICINAL AGENT COMPRISING THEREOF AND METHOD FOR TREATMENT | 2001 |
|
RU2275371C2 |
PHENOXYPYRIDINYLAMIDE DERIVATIVES, AND THEIR USE IN TREATMENT OF PDE4-MEDIATED DISEASE STATES | 2009 |
|
RU2509077C2 |
DERIVATIVES OF 3-SUBSTITUTED 4-ARYLQUINOLIN-2-ONE AS MODULATORS OF POTASSIUM CHANNEL | 1999 |
|
RU2240998C2 |
DERIVATIVES OF BENZIMIDAZOL, COMPOSITIONS CONTAINING THEM, OBTAINING AND APPLICATION | 2004 |
|
RU2346938C2 |
BENZAZEPINE DICARBOXAMIDE COMPOUND | 2016 |
|
RU2712248C2 |
AMINE DERIVATIVES AND THEIR USE FOR TREATMENT OF OPHTHALMOLOGICAL DISEASES AND ILLNESSES | 2008 |
|
RU2536040C2 |
HISTONES DEACETYLASES (HDACS) INHIBITORS | 2013 |
|
RU2629947C2 |
NEW AMINOPROPYLPHOSPHINIC ACIDS | 2000 |
|
RU2260595C2 |
NOVEL COMPOUNDS OF CONDENSED IMIDAZOLE POSSESSING OF CB2 RECEPTOR AGONIST PROPERTY | 2002 |
|
RU2312864C2 |
COMPOSITIONS AND METHODS OF TREATING NEURODEGENERATIVE DISEASES | 2008 |
|
RU2541430C2 |
Authors
Dates
2009-09-27—Published
2004-11-19—Filed